Low dose bleomycin and methotrexate in cervical cancer
- 1 February 1976
- Vol. 37 (2) , 660-664
- https://doi.org/10.1002/1097-0142(197602)37:2<660::aid-cncr2820370208>3.0.co;2-v
Abstract
Twenty patients with recurrent and disseminated carcinoma of the cervix were treated with Bleomycin, 10 mg/m2 weekly and Methotrexate, 10 mg/m2 every fourth day. Twelve of the 20 (60%) had a greater than 50% shrinking of measured tumor masses lasting a median remission time of 7.5 months. The data suggest that combination protracted chemotherapy with these drugs of metastatic cervical cancer might improve the outlook of patients with this condition.This publication has 2 references indexed in Scilit: